Trade Report: Today: Recent Investment Analysts’ Ratings Changes for Ionis Pharmaceuticals (IONS)

Today: Recent Investment Analysts’ Ratings Changes for Ionis Pharmaceuticals (IONS)

Ionis Pharmaceuticals (NASDAQ: IONS) has recently received a number of price target changes and ratings updates:

Shares of Ionis Pharmaceuticals Inc. (NASDAQ:IONS) opened at 46.01 on Monday. The stock’s market capitalization is $5.58 billion. Ionis Pharmaceuticals Inc. has a one year low of $19.59 and a one year high of $63.71. The stock has a 50 day moving average price of $34.28 and a 200 day moving average price of $30.74.

Ionis Pharmaceuticals (NASDAQ:IONS) last announced its quarterly earnings results on Wednesday, November 9th. The company reported $0.06 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.08 by $0.02. Ionis Pharmaceuticals had a negative net margin of 77.30% and a negative return on equity of 120.60%. The business earned $110.90 million during the quarter, compared to analysts’ expectations of $114.65 million. The business’s revenue was up 125.9% on a year-over-year basis. Equities analysts forecast that Ionis Pharmaceuticals Inc. will post ($1.06) earnings per share for the current year.

Related posts

Leave a Comment